Communications Biology· 2026Q1
Organelle associations and metabolic rewiring of size-defined hepatic lipid droplets
- 0citations
- Q1SCImago
- 2026year
Short summary
Hepatic lipid droplets (LDs) are sorted by size and organelle association, revealing large LDs (L-LDs) as mitochondrion-coupled fueling hubs and small LDs (S-LDs) as lysosome-coupled trafficking/turnover hubs.
AI-generated from the title and abstract; the full text is not read.
Key points
- A fractionation workflow resolves hepatic LDs by size and organelle association, defining intrinsic LD proteomes.
- Large LDs (L-LDs) are mitochondrion-coupled 'fueling hubs', while small LDs (S-LDs) are lysosome-coupled 'trafficking and turnover hubs'.
- Metabolic stress (fasting/steatosis) induces lysosomal machinery recruitment to S-LDs and mitochondrial recruitment to both LD pools.
- A 'parallel programs' model is proposed where S-LD-associated mitochondria power degradative machinery.
AI-generated from the title and abstract; the full text is not read.
Abstract
Abstract Lipid droplet (LD) size is a key determinant of hepatic lipid metabolism, yet the molecular programming routing size-defined subpopulations to distinct fates remains unclear. Here we show that a fractionation workflow resolves hepatic LDs by size and organelle association, defining a high-confidence intrinsic LD proteome. Moreover, comparative proteomics of fasted livers reveals a clear ‘division of labor’: Large LDs (L-LDs) function as specialized mitochondrion-coupled ‘putative fueling hubs’, whereas small LDs (S-LDs) serve as lysosome-coupled ‘putative trafficking and turnover hubs’. This interaction map is highly plastic; metabolic stress (fasting or steatosis) triggers a programmatic remodeling where lysosomal machinery is inducibly recruited to S-LDs. Crucially, in vivo stress recruits mitochondria to both pools, supporting a ‘parallel programs’ model where S-LD-associated mitochondria are hypothesized to power the energy-intensive degradative machinery. These findings establish that metabolic state leverages LD size to direct organelle partnerships, nominating the small-LD lysosomal axis as a critical regulatory node in metabolic-associated fatty liver disease (MAFLD).
The authors' abstract, as published at the source. Communications Biology, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biochemistry (Biochemistry, Genetics and Molecular Biology)
BiochemistryBiochemistry, Genetics and Molecular Biology